Portfolio company
Delve Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides metagenomic next-generation sequencing tests and diagnostic software to clinicians and laboratories for identifying pathogens in infectious diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
IDbyDNA
This company develops metagenomics software and diagnostic tests to identify pathogens and microorganisms for clinical laboratories, healthcare providers and researchers.
Biotia
This company develops genomic sequencing software and diagnostic tests to identify infectious diseases for hospitals, researchers and patients.
Noscendo
This company develops bioinformatic software and diagnostic platforms to identify pathogens in bloodstream infections for hospitals and clinical laboratories.
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
Pattern Biosciences
This company develops single-cell microbiology diagnostic systems for rapid bacterial identification and antibiotic susceptibility testing for clinical laboratories and hospital settings.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
Nanopath
This company develops point-of-care molecular diagnostic tests and hardware for pelvic and gynecologic infections to provide rapid results for healthcare providers and their patients.
DxLab
This company develops point-of-care molecular testing systems and rapid diagnostic tests for pathogens to serve healthcare providers and public health teams.
